Thyroid cancer diagnosis with transdermal probe 22G U/S versus EBUS-convex probe TBNA-B 22G and 19G: pros and cons

Expert Rev Med Devices. 2021 Feb;18(2):197-201. doi: 10.1080/17434440.2021.1880891. Epub 2021 Jan 29.

Abstract

Introduction: Thyroid cancer is usually diagnosed both with imaging techniques and transdermal biopsy. Laboratory tests are also included in the initial work-up.

Patients and methods: One hundred and thirty patients were included in our study with pathological imaging findings in the thyroid region. Biopsies were performed with 22 G with transdermal convex probe, EBUS 22 G Mediglobe® needle and 19 G Olympus® needle. We investigated the efficiency and safety of both techniques and identified the best candidates for each method.

Discussion: 19 G needle identified cancer types such as; Lymphoma, Medullary thyroid cancer, and Hurthle cell cancer, which we know from previous pathology studies that a larger sample is necessary for diagnosis. No safety issues were observed for both techniques and the EBUS technique produced more cell block material when 22 G needle was compared to transdermal biopsy in peritracheal lesions.

Conclusion: The method of biopsy should be made based on the size and accessibility of the lesion.

Keywords: 19g needle; 22g; EBUS; convex; thyroid cancer; transdermal biopsy.

Publication types

  • Comparative Study

MeSH terms

  • Analysis of Variance
  • Endoscopic Ultrasound-Guided Fine Needle Aspiration* / methods
  • Humans
  • Laryngeal Masks
  • Needles
  • Retrospective Studies
  • Thyroid Neoplasms / diagnosis*
  • Thyroid Neoplasms / pathology*